Clinical Trial Update: A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL) [Phase 3]

View source ↗

Summary

A multicenter Phase 3 randomized trial evaluates adding toripalimab to sequential chemoradiotherapy versus chemoradiotherapy alone in newly diagnosed early-stag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: NK/T Cell Lymphoma Nos | Phase 3 | Status: RECRUITING